封面
市场调查报告书
商品编码
1667686

2025 年全球药物输注系统市场

Drug Infusion Systems Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年药物注射系统的市场规模将快速成长。预计到 2029 年将以 9.3% 的复合年增长率成长,达到 204.6 亿美元。

预测期内的成长归因于向一次性系统的转变、慢性病盛行率的上升、门诊护理设施的扩大、个人化医疗和剂量优化以及居家照护需求的增加。预测期内的主要趋势包括无线连接和远端监控、与电子健康记录(EHR) 的整合、智慧型帮浦技术、个人化医疗和自适应剂量以及微创输液技术。

预计慢性病发病率的不断上升将推动未来几年药物输注系统市场的扩张。癌症、糖尿病、心血管疾病和自体免疫疾病等慢性疾病通常需要长期或持续的液体疗法。药物输注系统为患有这些疾病的患者提供了一种安全、高效和有效的药物输送方法。中低收入国家的慢性病盛行率成长速度快于高所得国家。糖尿病是导致肾衰竭、心臟病、中风、失明和下肢截肢的主要原因。 2024 年 2 月,美国美国管制与预防中心 (CDC) 报告称,患有多种慢性病的美国数量呈上升趋势,其中 42% 患有两种或两种以上的慢性病,​​12% 患有五种或五种以上的慢性病。因此,慢性病发病率的上升正在推动药物输注系统市场的成长。

本报告调查了全球药物注射系统市场,并总结了市场概况和特点、主要趋势、市场影响因素分析、市场规模趋势和预测、各个细分市场的详细分析、地区/主要国家、竞争格局以及主要企业的概况。

目录

第一章执行摘要

第二章 药物输注系统市场:特点

第三章药物输注系统市场:趋势与策略

第 4 章 药物输注系统市场:宏观经济情境(包括利率、通货膨胀、地缘政治、COVID-19 及其对市场復苏的影响)

第五章全球药物输注系统市场:成长分析与策略分析框架

  • PESTEL 分析:成长推进因素/阻碍要素
  • 最终用户产业分析
  • 市场成长分析
  • 市场规模趋势和成长率
  • 市场规模成长预测
  • 总潜在市场 (TAM)

6. 药物输注系统市场区隔

  • 市场规模趋势与预测:按产品类型
  • 合成橡胶注射系统
  • 一次性输液系统
  • 注射器注射系统
  • 蠕动帮浦
  • 多通道泵浦
  • 病患自控镇痛 (PCA) 泵
  • 胰岛素帮浦
  • 植入式输液系统
  • 市场规模趋势与预测:按管理方式
  • 静脉
  • 皮下
  • 动脉
  • 硬脊膜外麻醉
  • 其他的
  • 市场规模趋势与预测:按应用
  • 肿瘤和化疗
  • 糖尿病
  • 止痛药
  • 营养
  • 孩子们
  • 其他的
  • 市场规模趋势与预测:按最终用户
  • 医院
  • 门诊手术中心
  • 诊断中心
  • 其他的
  • 合成橡胶注射系统子类型的市场规模趋势及预测
  • 无排气合成橡胶泵
  • 通风合成橡胶泵
  • 一次性注射系统子类型市场规模趋势及预测
  • 一次性使用输液泵
  • 一次性部件输液器
  • 注射器注射系统子类型的市场规模趋势及预测
  • 手动注射输液帮浦
  • 电动注射输液帮浦
  • 蠕动帮浦亚型市场规模趋势及预测
  • 单通道蠕动泵
  • 多通道蠕动泵
  • 市场规模趋势及预测:按多通道帮浦子类型划分
  • 通用多通道泵浦
  • 用于特定治疗的多通道泵
  • 市场规模趋势及预测:依 PCA 泵浦亚型划分
  • 电子PCA泵
  • 机械PCA泵
  • 市场规模趋势及预测:以胰岛素帮浦亚型划分
  • 持续皮下胰岛素输注 (CSII) 泵
  • 贴片胰岛素泵
  • 植入式註射系统各亚型市场规模趋势及预测
  • 用于治疗慢性疼痛的植入式泵
  • 植入式化疗泵

第 7 章药物输注系统市场:区域与国家分析

  • 市场规模趋势与预测:按地区
  • 市场规模趋势与预测:依国家

8. 亚太地区药物输注系统市场

9. 中国药物输注系统市场

第 10 章印度药物输注系统市场

第十一章日本药物输注系统市场

12. 澳洲药物输注系统市场

13. 印尼药物输注系统市场

第 14 章韩国药物输注系统市场

15. 西欧药物注射系统市场

第十六章英国药物输注系统市场

17. 德国药物注射系统市场

18. 法国药物注射系统市场

19. 义大利药物注射系统市场

20. 西班牙药物注射系统市场

21. 东欧药物注射系统市场

22. 俄罗斯药物注射系统市场

23. 北美药物输注系统市场

第 24 章美国药物输注系统市场

25. 加拿大药物注射系统市场

26. 南美洲药物注射系统市场

27. 巴西药物注射系统市场

28. 中东药物输注系统市场

29. 非洲药物注射系统市场

第 30 章药物输注系统市场:竞争格局与公司概况

  • 竞争格局
  • 公司简介
    • Medtronic plc
    • Baxter International Inc.
    • ICU Medical Inc.
    • Becton Dickinson and Company
    • Smiths Group plc

第 31 章药物输注系统市场:其他领先与创新企业

  • Tandem Diabetes Care Inc.
  • Terumo Corporation
  • Halyard Health Inc.
  • Insulet Corporation
  • Zyno Medical Inc.
  • Braun Melsungen AG
  • Flowonix Medical Inc.
  • IRadimed Corporation
  • Moog Inc.
  • Debiotech SA
  • Fresenius SE & Co. KGaA
  • Johnson & Johnson
  • Hospira
  • Alaris Health Systems Inc.
  • B. Braun Melsungen AG

第 32 章。

第 33 章药物输注系统市场:主要併购

第 34 章药物输注系统市场:最新趋势

第 35 章药物输注系统市场:高潜力国家、细分市场与策略

  • 提供最多新机会的国家
  • 提供最新机会的市场区隔
  • 成长策略

第 36 章 附录

简介目录
Product Code: r24097

Drug infusion systems, classified as medical devices, are instrumental in delivering medications and fluids into a patient's body through a catheter or needle. This method of administration is commonly employed in hospitals, clinics, and various healthcare settings to dispense medications such as pain relievers, antibiotics, chemotherapy drugs, and fluids to patients.

The primary categories of drug infusion systems encompass elastomeric infusion systems, disposable infusion systems, syringe infusion systems, peristaltic pumps, multi-channel pumps, patient-controlled analgesia (PCA) pumps, insulin pumps, and implantable infusion systems. Elastomeric infusion systems, for instance, are flexible containers designed to provide a consistent rate of medication delivery for short-term infusion therapy. They find application in hospitals, clinics, and home care settings for short-term drug infusion therapy. These systems are versatile, administered through various modes such as intravenous, subcutaneous, arterially, epidurally, and others. They cater to diverse medical applications, including oncology and chemotherapy, diabetes, analgesia, nutrition, hematology, pediatrics, and more. Various end-users, such as hospitals, ambulatory surgical centers, diagnostic centers, and others, utilize elastomeric infusion systems for their respective needs.

The drug infusion systems market research report is one of a series of new reports from The Business Research Company that provides drug infusion systems market statistics, including drug infusion systems industry global market size, regional shares, competitors with a drug infusion systems market share, detailed drug infusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the drug infusion systems industry. This drug infusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The drug infusion systems market size has grown strongly in recent years. It will grow from$13.42 billion in 2024 to $14.34 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to shift to electronic infusion devices, increased prevalence of chronic diseases, patient care advancements, home-based infusion therapy, expansion of ambulatory care settings

The drug infusion systems market size is expected to see strong growth in the next few years. It will grow to $20.46 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to shift towards disposable systems, rising prevalence of chronic diseases, expansion of ambulatory care facilities, personalized medicine and adaptive dosing, increasing demand for home-based care. Major trends in the forecast period include wireless connectivity and remote monitoring, integration with electronic health records (ehr), smart pump technology, personalized and adaptive dosing, minimally invasive infusion techniques.

The growing prevalence of chronic diseases is anticipated to drive the expansion of the drug infusion system market in the future. Chronic diseases such as cancer, diabetes, cardiovascular disease, and autoimmune disorders frequently necessitate long-term or continuous infusion therapy. Drug infusion systems provide a safe, efficient, and effective means of delivering medication to patients with these conditions. The prevalence of chronic diseases is rising more rapidly in low- and middle-income countries compared to high-income nations. Diabetes, in particular, is a significant contributor to renal failure, heart attacks, strokes, blindness, and lower limb amputations. For example, in February 2024, reports from the Centers for Disease Control and Prevention (CDC), a U.S.-based organization, indicated that an increasing number of Americans are dealing with multiple chronic conditions, with 42% reporting two or more conditions and 12% experiencing five or more. Therefore, the rising prevalence of chronic diseases is driving the growth of the drug infusion system market.

The rise in healthcare expenditure is expected to drive the growth of the drug infusion systems market in the future. Healthcare expenditure refers to the total amount allocated for healthcare goods and services within a specific timeframe, usually a year. As healthcare spending increases, hospitals, clinics, and other healthcare institutions gain more resources to invest in advanced drug infusion systems, resulting in higher demand for these devices. For example, in May 2024, reports from the Office for National Statistics (ONS), a UK-based national statistical institute, indicated that total healthcare spending increased by 5.6% in nominal terms from 2022 to 2023, compared to a growth rate of only 0.9% in 2022. Therefore, the increase in healthcare expenditure is likely to propel the growth of the drug infusion systems market.

Leading companies in the drug infusion systems market are focusing on developing advanced technologies, such as cloud-based infusion management systems, to improve patient care, enhance accuracy, and streamline the management of infusion therapies. Cloud-based infusion management systems are digital platforms that enable the monitoring, administration, and tracking of medication infusions via the cloud. For example, in June 2023, Eitan Medical, a U.S.-based global leader in advanced infusion therapy and drug delivery solutions, launched Eitan Insights, a new cloud-based infusion management system tailored to meet the specific needs of home and specialty infusions. Eitan Insights provides healthcare professionals with real-time data and analytics, allowing them to monitor patients remotely and adjust treatment plans as necessary. This system enhances medication safety by minimizing the risk of errors and improving adherence to prescribed protocols.

Major players in the drug infusion systems market are directing their efforts towards developing innovative products, such as medication delivery systems, to gain a competitive advantage. Medication delivery systems encompass a diverse range of innovative tools and systems designed to enhance the safe, accurate, and efficient administration of medications. For instance, in February 2023, Mindray Medical International Limited, a China-based manufacturer of medical instrumentation, launched the BeneFusion i/u Series Infusion Systems. These systems provide unparalleled accuracy, adaptive customization, and remarkable simplicity, ensuring guaranteed medication safety in various clinical settings. The BolusGUARD motorized syringe loading system with patent-pending automatic clutch technology prevents loading errors, securing every step of the infusion process. The user-friendly interface and intuitive design streamline workflows and enhance the user experience.

In March 2022, Fresenius Kabi, a pharmaceutical company based in Germany, acquired Ivenix Inc. for $240 million. This strategic acquisition aims to expand Fresenius Kabi's portfolio of infusion therapy products and strengthen its position in the infusion system market. The acquisition positions Fresenius Kabi to offer a comprehensive and leading set of premium infusion therapy products for the benefit of patients, customers, and stakeholders. Ivenix, the acquired company, is a medical technology company based in the United States, specializing in the development of infusion systems.

Major companies operating in the drug infusion systems market include Medtronic plc, Baxter International Inc., ICU Medical Inc., Becton Dickinson and Company, Smiths Group plc, Tandem Diabetes Care Inc., Terumo Corporation, Halyard Health Inc., Insulet Corporation, Zyno Medical Inc., Braun Melsungen AG, Flowonix Medical Inc., IRadimed Corporation, Moog Inc., Debiotech S.A., Fresenius SE & Co. KGaA, Johnson & Johnson, Hospira, Alaris Health Systems Inc., B. Braun Melsungen AG, Disetronic Medical Systems AG, Accu-Chek, Abbott Diabetes Care Inc., Novo Nordisk A/S, Eli Lilly and Company, Sanofi-Aventis, Ypsomed Holding AG, Valeritas Inc.

North America was the largest region in the drug infusion systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drug infusion systems market report during the forecast period. The regions covered in the drug infusion systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the drug infusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The drug infusion systems market consists of sales of smart pumps, syringe pumps, enteral infusion systems, and topical infusion systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Infusion Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug infusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug infusion systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug infusion systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Elastomeric Infusion System; Disposable Infusion System; Syringe Infusion System; Peristaltic Pump; Multi-Channel Pump; Patient-Controlled Analgesia (PCA) Pump; Insulin Pump; Implantable Infusion System
  • 2) By Route Of Administration: Intravenous; Subcutaneous; Arterial; Epidural; Other Routes Of Administration
  • 3) By Application: Oncology And Chemotherapy; Diabetes; Analgesia; Nutrition; Hematology; Pediatrics; Other Applications
  • 4) By End User: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End Users
  • Subsegments:
  • 1) By Elastomeric Infusion System: Non-Vented Elastomeric Pumps; Vented Elastomeric Pumps
  • 2) By Disposable Infusion System: Disposable Infusion Pumps; IV Sets With Disposable Components
  • 3) By Syringe Infusion System: Manual Syringe Infusion Pumps; Electric Syringe Infusion Pumps
  • 4) By Peristaltic Pump: Single-Channel Peristaltic Pumps; Multi-Channel Peristaltic Pumps
  • 5) By Multi-Channel Pump: Multi-Channel Infusion Pumps For General Use; Multi-Channel Pumps For Specific Therapies
  • 6) By Patient-Controlled Analgesia (PCA) Pump: Electronic PCA Pumps; Mechanical PCA Pumps
  • 7) By Insulin Pump: Continuous Subcutaneous Insulin Infusion (CSII) Pumps; Patch Insulin Pumps
  • 8) By Implantable Infusion System: Implantable Pumps For Chronic Pain; Implantable Pumps For Chemotherapy
  • Companies Mentioned: Medtronic plc; Baxter International Inc.; ICU Medical Inc.; Becton Dickinson and Company; Smiths Group plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Infusion Systems Market Characteristics

3. Drug Infusion Systems Market Trends And Strategies

4. Drug Infusion Systems Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Drug Infusion Systems Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drug Infusion Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drug Infusion Systems Market Growth Rate Analysis
  • 5.4. Global Drug Infusion Systems Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drug Infusion Systems Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drug Infusion Systems Total Addressable Market (TAM)

6. Drug Infusion Systems Market Segmentation

  • 6.1. Global Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Elastomeric Infusion System
  • Disposable Infusion System
  • Syringe Infusion System
  • Peristaltic Pump
  • Multi-Channel Pump
  • Patient-Controlled Analgesia (PCA) Pump
  • Insulin Pump
  • Implantable Infusion System
  • 6.2. Global Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous
  • Subcutaneous
  • Arterial
  • Epidural
  • Other Routes Of Administration
  • 6.3. Global Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology And Chemotherapy
  • Diabetes
  • Analgesia
  • Nutrition
  • Hematology
  • Pediatrics
  • Other Applications
  • 6.4. Global Drug Infusion Systems Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Other End Users
  • 6.5. Global Drug Infusion Systems Market, Sub-Segmentation Of Elastomeric Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Vented Elastomeric Pumps
  • Vented Elastomeric Pumps
  • 6.6. Global Drug Infusion Systems Market, Sub-Segmentation Of Disposable Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Infusion Pumps
  • IV Sets With Disposable Components
  • 6.7. Global Drug Infusion Systems Market, Sub-Segmentation Of Syringe Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual Syringe Infusion Pumps
  • Electric Syringe Infusion Pumps
  • 6.8. Global Drug Infusion Systems Market, Sub-Segmentation Of Peristaltic Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Channel Peristaltic Pumps
  • Multi-Channel Peristaltic Pumps
  • 6.9. Global Drug Infusion Systems Market, Sub-Segmentation Of Multi-Channel Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Multi-Channel Infusion Pumps For General Use
  • Multi-Channel Pumps For Specific Therapies
  • 6.10. Global Drug Infusion Systems Market, Sub-Segmentation Of Patient-Controlled Analgesia (PCA) Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Electronic PCA Pumps
  • Mechanical PCA Pumps
  • 6.11. Global Drug Infusion Systems Market, Sub-Segmentation Of Insulin Pump, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Continuous Subcutaneous Insulin Infusion (CSII) Pumps
  • Patch Insulin Pumps
  • 6.12. Global Drug Infusion Systems Market, Sub-Segmentation Of Implantable Infusion System, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Pumps For Chronic Pain
  • Implantable Pumps For Chemotherapy

7. Drug Infusion Systems Market Regional And Country Analysis

  • 7.1. Global Drug Infusion Systems Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drug Infusion Systems Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Infusion Systems Market

  • 8.1. Asia-Pacific Drug Infusion Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Infusion Systems Market

  • 9.1. China Drug Infusion Systems Market Overview
  • 9.2. China Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Infusion Systems Market

  • 10.1. India Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Infusion Systems Market

  • 11.1. Japan Drug Infusion Systems Market Overview
  • 11.2. Japan Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Infusion Systems Market

  • 12.1. Australia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Infusion Systems Market

  • 13.1. Indonesia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Infusion Systems Market

  • 14.1. South Korea Drug Infusion Systems Market Overview
  • 14.2. South Korea Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Infusion Systems Market

  • 15.1. Western Europe Drug Infusion Systems Market Overview
  • 15.2. Western Europe Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Infusion Systems Market

  • 16.1. UK Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Infusion Systems Market

  • 17.1. Germany Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Infusion Systems Market

  • 18.1. France Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Infusion Systems Market

  • 19.1. Italy Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Infusion Systems Market

  • 20.1. Spain Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Infusion Systems Market

  • 21.1. Eastern Europe Drug Infusion Systems Market Overview
  • 21.2. Eastern Europe Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Infusion Systems Market

  • 22.1. Russia Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Infusion Systems Market

  • 23.1. North America Drug Infusion Systems Market Overview
  • 23.2. North America Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Infusion Systems Market

  • 24.1. USA Drug Infusion Systems Market Overview
  • 24.2. USA Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Infusion Systems Market

  • 25.1. Canada Drug Infusion Systems Market Overview
  • 25.2. Canada Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Infusion Systems Market

  • 26.1. South America Drug Infusion Systems Market Overview
  • 26.2. South America Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Infusion Systems Market

  • 27.1. Brazil Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Infusion Systems Market

  • 28.1. Middle East Drug Infusion Systems Market Overview
  • 28.2. Middle East Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Infusion Systems Market

  • 29.1. Africa Drug Infusion Systems Market Overview
  • 29.2. Africa Drug Infusion Systems Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drug Infusion Systems Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drug Infusion Systems Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Infusion Systems Market Competitive Landscape And Company Profiles

  • 30.1. Drug Infusion Systems Market Competitive Landscape
  • 30.2. Drug Infusion Systems Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. ICU Medical Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Smiths Group plc Overview, Products and Services, Strategy and Financial Analysis

31. Drug Infusion Systems Market Other Major And Innovative Companies

  • 31.1. Tandem Diabetes Care Inc.
  • 31.2. Terumo Corporation
  • 31.3. Halyard Health Inc.
  • 31.4. Insulet Corporation
  • 31.5. Zyno Medical Inc.
  • 31.6. Braun Melsungen AG
  • 31.7. Flowonix Medical Inc.
  • 31.8. IRadimed Corporation
  • 31.9. Moog Inc.
  • 31.10. Debiotech S.A.
  • 31.11. Fresenius SE & Co. KGaA
  • 31.12. Johnson & Johnson
  • 31.13. Hospira
  • 31.14. Alaris Health Systems Inc.
  • 31.15. B. Braun Melsungen AG

32. Global Drug Infusion Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Infusion Systems Market

34. Recent Developments In The Drug Infusion Systems Market

35. Drug Infusion Systems Market High Potential Countries, Segments and Strategies

  • 35.1 Drug Infusion Systems Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drug Infusion Systems Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drug Infusion Systems Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer